TherapeuticsMD (TXMD) Current Assets (2010 - 2026)

TherapeuticsMD has reported Current Assets for 17 years, with the latest figure at $15.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 21.99% year-over-year to $15.3 million; the trailing twelve-month figure through Mar 2026 stood at $15.3 million (up 21.99% YoY), and the FY2025 full-year result was $14.4 million, up 17.83% from the prior year.
• Current Assets for Q1 2026 stood at $15.3 million, up from $14.4 million in the prior quarter.
• The five-year high for Current Assets was $98.6 million in Q2 2022, with the low at $11.5 million in Q1 2024.
• Historically, Current Assets has averaged $30.4 million across 5 years, with a median of $14.5 million in 2025.
• Annual changes were most pronounced in 2023 — Current Assets slumped 80.11% — and 2026, when it advanced 21.99%.
• TherapeuticsMD's Current Assets stood at $55.4 million in 2022, then plunged by 78.69% to $11.8 million in 2023, then gained by 3.93% to $12.3 million in 2024, then increased by 17.83% to $14.4 million in 2025, then grew by 5.66% to $15.3 million in 2026.
• The last three Current Assets figures came in at $15.3 million (Q1 2026), $14.4 million (Q4 2025), and $14.5 million (Q3 2025), per Business Quant data.